Clinical trial
Safety and Efficacy of Nitrogen Mustard in Treatment of Mycosis Fungoides
NCT00168064 · Yaupon Therapeutics, Industry · Completed
Key facts
| NCT number | NCT00168064 |
|---|---|
| Title | Safety and Efficacy of Nitrogen Mustard in Treatment of Mycosis Fungoides |
| Official title | A Phase II Pivotal Trial to Evaluate the Safety and Efficacy of Nitrogen Mustard (NM) 0.02% Ointment Formulations in Patients With Stage I or IIA Mycosis Fungoides (MF) |
| Lead sponsor | Yaupon Therapeutics, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Mycosis Fungoides |
| Intervention type | Drug |
| Interventions | mechlorethamine-MCH (nitrogen mustard) |
| Enrollment | 260 |
| Start date | May 1, 2006 |
| Primary completion | Aug 1, 2010 |
| Completion | Aug 1, 2011 |
| First posted | Sep 14, 2005 |
| Last update posted | Oct 31, 2012 |
| Countries | United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: